Skip to main content
Are you a healthcare professional?Join GLP1Zoom for HCPs →
GLP1ZoomFind provider

Switching guide

Switching from Saxenda to Wegovy

Dose conversion table, transition timeline, side-effect expectations, и FAQ для patients moving from Saxenda to Wegovy.

Why patients switch from Saxenda to Wegovy

  • Weekly dosing — Saxenda требует daily; newer GLP-1s are weekly
  • Higher efficacy — newer GLP-1s produce 2-3× more weight loss

Dose conversion: SaxendaWegovy

Use this table as a starting reference только. Final dose depends on your tolerance, weight-loss trajectory, и prescriber guidance. Never self-titrate based on a chart.

Saxenda doseWegovy doseNote
AnyDifferent mechanism (liraglutide → semaglutide). No direct conversion.

Transition timeline

Plan на 2-week prep + 12-week evaluation window. Most weight-loss outcomes can be re-assessed at the 12-week mark на the new medication.

FAQ — SaxendaWegovy

Can I take Saxenda and Wegovy together?

No. Combining GLP-1 medications isn't done outside clinical trials. Stop Saxenda before starting Wegovy; the long half-lives mean overlap occurs naturally.

Will I lose ground when switching from Saxenda to Wegovy?

Possibly temporarily. Most patients maintain weight during a clean switch when restart dose is appropriate. The bigger risk is regression if the switch fails to match Saxenda efficacy. Plan а 12-week evaluation window.

Does insurance cover Wegovy if it covered Saxenda?

Different molecule means different formulary placement. Run a fresh prior authorization для Wegovy — coverage of Saxenda doesn't transfer automatically.

How long does Saxenda stay in my system after the last dose?

Liraglutide has a 13-hour half-life — effects clear in 2-3 days. Daily dosing means transitions are quicker.

Next steps

Before switching, read our full Saxenda review and Wegovy review. For provider options that carry both medications, see our Saxenda vs Wegovy comparison and Saxenda alternatives hub.

Not medical advice. Switching GLP-1 medications must be done с prescriber supervision. This guide is editorial summary based на published prescribing information and clinical guidance. Full medical disclaimer.